Canopy Growth: Bank Of America Forecasts Q2 Net Revenues Of $117.4 Million

Yesterday, Canopy Growth Corp (TSX: WEED) (NYSE: CGC) announced that they would hold their second quarter fiscal 2021 results before the market open on November 9th. In connection with this, Bank of America Securities released a note reiterating their buy rating and C$30 price target on Canopy.

Bryan D. Spillane, Bank of America’s analyst, justifies the rating by highlighting “Canopy’s share position, robust balance sheet and ind. conditions,” and, “we see management changes, right-sizing of operations, and its enviable cash and share position as all reasons to believe that Canopy can be a long term leader in the cannabis sector.”

Spillane adds that they expect fiscal 2021 to be a transition year, “as it resets its strategic focus, rolls out a new organizational design and implements operational and supply chains productivity programs,” and hopes for management to give an update on COVID impacts, growth in the value segment and reviews of their 2.0 product lineup.

Bank of America currently forecasts Canopy to have net sales of C$117.4 million, while the street estimate is C$117.2 million. This is up from their first quarter sales of C$110.4 million, mainly on the increase in recreational sales. At the same time, they guide that Canadian and International medical, along with the “other” revenue which consists of skin care, and hardware, will be flat quarter over quarter.

They attribute that the sales growth will come from additional store openings, but add that the growth will be offset “by lower revenue/kg due to the category’s downtrading to the value segment, improved ordering by retailers as they became more business-oriented.” Spillane adds that licensed producers taking share away from the illicit market via the value segment is beneficial in the long run. Licensed producers need to have an “up trading strategy to drive profitability longer term, which we think will take time as brand loyalty is just in its infancy.”

Currently, they have the full-year fiscal 2021 revenue estimate at C$508.7 million, but qualify it by stating that if store openings rise above 1,300 locations in calendar 2020, then there is upside to that estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

First Majestic Posts Record Cash Flows In Q1 As Production Costs Fall

Brazil Potash Secures Funding In Support Of US$2.5 Billion Autozales Project

Related News

CloudMD: Canaccord Drops Price Target To $3.00 Following MindBeacon Deal

On November 15th, CloudMD Software & Services (TSXV: DOC) announced that they would be acquiring...

Friday, November 19, 2021, 04:14:00 PM

Equinox: BMO Lowers Price Target After Second Blockade In Nine Months

On June 22nd, Equinox Gold Corp. (TSX: EQX) announced that there has been illegal blockades set...

Thursday, June 24, 2021, 04:14:00 PM

WeedMD: Canaccord Reiterates Price Target After Earnings

WeedMD (TSXV: WMD) reported their first-quarter financials of 2021 on June 29th. The company reported...

Thursday, July 1, 2021, 03:09:00 PM

Medipharm Labs: Canaccord Drops Target To Just $0.10

On May 16, Medipharm Labs (TSX: LABS) reported its first quarter financial results. The company...

Tuesday, May 24, 2022, 11:37:00 AM

Tesla: Canaccord Doubles Price Target To $1,071

On Monday, one of the more bearish Tesla Inc. (NASDAQ: TSLA) analysts flipped bullish, and...

Tuesday, April 13, 2021, 11:41:00 AM